I think everyone here knows about this situation in the USA, and there will be money made in this industry. The question is, why will CPH be making that money? Yes, they are ostensibly in the industry, but they don't have an established business, just their latest pie in the sky ideas and promises with a trail of failed pie in the sky ideas and broken promises behind them, which can reasonably lead one to the assumption that the pattern will continue (the 'insanity is continually trying the same thing and expecting different results' quote comes to mind).
Sure, it's reasonable to expect that the entire pharmaceutical industry will make a profit from this sector. Big pharma will take pretty much all of it, not some dinky little smoke and mirrors setup with the track record, company structure and management type of CPH.
Why do you think CPH specifically has something for shareholders to get excited about, as opposed to CPH's many competitors, primarily the big ones, which clearly stand to gain the most through economies of scale, brand recognition and trust, existing networks, capital strength to get projects going, etc etc etc?
Expand